Compare IQVIA Holdings Inc. Common Stock (IQV) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IQVIA Holdings Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? IQVIA Holdings Inc. Common Stock trades at $259.88 (market cap $42.61B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 18.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and IQVIA Holdings Inc. Common Stock is trading nearer its 52-week high, SELLAS Life Sciences Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals.
| IQV | SLS | |
|---|---|---|
Market Cap | $42.61B | $2.27B |
Volume | 988,398 | 4,179,659 |
Sector | Health | Health |
52-Week High | $275.02 | $15.46 |
52-Week Low | $156.66 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $56.77B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IQVIA Holdings Inc. Common Stock
IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
